UroGen Pharma (URGN) to Offer $150M in Common Stock
Tweet Send to a Friend
UroGen Pharma Ltd. (Nasdaq: URGN) announced that it intends to offer and sell $150 million of its ordinary shares in ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
